Pembrolizumab vs. chemotherapy in the first-line setting of PD-L1 ≥ 50% metastatic non-small cell lung cancer: a real-world cost-effectiveness analysis
Liu B, Parmar A, Luo J, Dai WF, Chan KKW. Eur J Health Econ. 2025; Oct 8 [Epub ahead of print].
Publications
Impact of immigration status on survival among stage 1 and 2 HER2-positive and triple-negative breast cancer in Ontario, Canada
Fatiregun O, Sutradhar R, Podolsky S, Eisen A, Paszat L, Rakovitch E. Cancer Med. 2025; 14(19):e71288.
Practice patterns and outcomes in cancer patients developing immune checkpoint inhibitors-related AKI
Blanchette P, Reid J, Richard L, Shariff SZ, Raphael J, Earle CC, Garg AX, Kitchlu A. Nephrol Dial Transplant. 2025; gfaf191. Epub 2025 Sep 27.
COVID-19 impacts on the breast cancer care pathway among systemically marginalized communities in Ontario
Lofters AK, Premranjith P, Gayowksy A, Khalil I, Covelli AM, Daniel JM. Cancer Causes Control. 2025; Sep 24 [Epub ahead of print].
Medical imaging and pediatric and adolescent hematologic cancer risk
Smith-Bindman R, Alber SA, Kwan ML, Pequeno P, Bolch WE, Bowles EJA, Greenlee RT, Stout NK, Weinmann S, Moy LM, Stewart C, Francisco M, Kofler C, Duncan JR, Ducore J, Mahendra M, Pole JD, Miglioretti DL. N Engl J Med. 2025; Sep 17 [Epub ahead of print].
Development of an electronic medical record-based score for heart failure prediction in cancer survivors
Soh CH, Nguyen L, Chu A, Salim A, Abdel-Qadir H, Marwick TH. JACC Adv. 2025; 4(10 Pt 2):102129. Epub 2025 Sep 12.
Association of neighborhood socioeconomic status and ethnic diversity with failure to rescue in curative-intent colorectal cancer surgery: a population-based cohort study
Bondzi-Simpson A, Ribeiro T, Covelli A, Lofters A, Sutradhar R, Snyder RA, Clarke CN, Coburn NG, Hallet J. Ann Surg. 2025 Sep 3 [Epub ahead of print].
Physical morbidities in survivors of testicular germ cell tumors during childhood, adolescence, and young adulthood: a population-based retrospective matched cohort study
Ajaj R, Lau C, Gupta S, Baxter NN, Pole JD, Shaikh F, Nathan PC. EClinicalMedicine. 2025; 88:103447.
Real-world outcomes of transplant ineligible older adults with multiple myeloma treated with novel regimens: a population-based retrospective cohort study
Abdallah N, Mian H, Seow H, Pond GP, Gayowsky A, Visram A, Costa LJ, Wildes TM, Fonseca R, Pawlyn C, Cook G, Kumar S, Chakraborty R. Am J Hematol. 2025; Aug 29 [Epub ahead of print].
Outcomes following exposure to drug interactions with ibrutinib in patients with chronic lymphocytic leukaemia
Hoang T, Cheung MC, Juurlink DN, Chan KKW, Lau C, Liu N, Abdel-Qadir H, Prica A, Hay AE, Vijenthira A, Mozessohn L. Br J Haematol. 2025; Aug 29 [Epub ahead of print].